Torres, Laura

Broad Activity for the Pivekimab Sunirine (PVEK, IMGN632), Azacitidine, and Venetoclax Triplet in High-Risk Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Daver, Naval, Montesinos, Pau , Aribi, Ahmed , Marconi, Giovanni , Altman, Jessica K. , Burke, Patrick W. , Walter, Roland B. , Thomas, Xavier , Jeyakumar, Deepa , Todisco, Elisabetta , Begna, Kebede H. , Gastaud, Lauris, Fuente, Adolfo de la , Mendez, Lourdes , Vey, Norbert , Récher, Christian , Longval, Thomas , Kapp‐Schwoerer, Silke, Schliemann, Christoph , Konopleva, Marina, Torres, Laura , Sallman, David A. , Marcucci, Guido , Pemmaraju, Naveen , Sloss, Callum M., Malcolm, Kara E, Sweet, Kendra , Montesinos, Pau , Walter, Roland B , Daver, Naval , Wang, Eunice S. , Roboz, Gail J. , Gaïdano, Gianluca , DeAngelo, Daniel J. , Erba, Harry Paul , Advani, Anjali S. , Curti, Antonio , Vyas, Paresh , Boissel, Nicolas , Platzbecker, Uwe , Martinelli, Giovanni , Kantarjian, Hagop M. , Zweidler-McKay, Patrick A

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 145-149

10.1182/blood-2022-158030